Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.69 +0.12 (+0.12%)
Streaming Delayed Price Updated: 2:49 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Exact Sciences Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
News headline image
3 Unpopular Stocks We Steer Clear Of
Wall Street’s bearish price targets for the stocks in this article signal serious concerns. Such forecasts are uncommon in an industry where maintaining cordial corporate relationships often trumps... 
Via StockStory
News headline image
1 Healthcare Stock for Long-Term Investors and 2 We Avoid
Personal health and wellness is one of the many secular tailwinds for healthcare companies. Those leading the charge have realized strong financial performance, and over the past six months, the... 
Via StockStory
Topics Stocks
News headline image
3 Overrated Stocks That Concern Us
The stocks featured in this article are seeing some big returns. Over the past month, they’ve outpaced the market due to some combination of positive news, upbeat results, or supportive macro... 
Via StockStory
News headline image
Here's Why Grail Soared, Again, in November ↗
A combination of operational improvements and developments at its key rival bolstered the stock recently. 
Via The Motley Fool
Exact Sciences Stock Soars To 4-Year High Even As Wall Street Piles On Downgrades After Abbott Deal — Retail Traders Take Profits ↗
Via Stocktwits
Exact Sciences Stock Falls Premarket Despite Wall Street Calling For A Triple-Digit Abbott Takeover ↗
Via Stocktwits
News headline image
This Top Dividend King Just Became an Even Better Buy ↗
The healthcare leader wants to make waves in a potentially highly lucrative market. 
Via The Motley Fool
News headline image
Unusual volume stocks are being observed in Monday's session. ↗
Let's explore the current happenings on the US markets on Monday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
News headline image
Q3 Earnings Highs And Lows: Exact Sciences (NASDAQ:EXAS) Vs The Rest Of The Immuno-Oncology Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the immuno-oncology industry, including Exact Sciences (NASDAQ:EXAS) and its peers. 
Via StockStory
Topics Artificial Intelligence
News headline image
Biggest Stock Movers Today, Nov. 20: PACS, BBWI, & More ↗
On a big day for tech stocks, some other less well-known companies saw even larger moves. 
Via The Motley Fool
Topics Artificial Intelligence Stocks
News headline image
Why Exact Sciences Rallied Over 50% This Week ↗
The company received a buyout offer from Abbot Labs. 
Via The Motley Fool
News headline image
Why Exact Sciences Stock Surged Today ↗
A healthcare giant covets the cancer screening leader's technology. 
Via The Motley Fool
News headline image
Tech Stocks Fall Despite Nvidia's Beat, Walmart Jumps 6%: What's Moving Markets Thursday? ↗
Nvidia Corp. (NASDAQ:NVDA) delivered another blockbuster quarter and raised its outlook, but even that wasn't enough to lift Wall Street on Thursday. 
Via Benzinga
News headline image
Nutex Health Posts Strong Q3 Results, Joins PACS Group, Walmart, Cerence And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
News headline image
Abbott's $21 Billion Exact Sciences Buyout Reshapes Cancer Diagnostics ↗
Abbott will acquire Exact Sciences for $21 billion, adding Cologuard and expanding its diagnostics portfolio as analysts highlight growth and valuation momentum. 
Via Benzinga
News headline image
Abbott To Acquire Exact Sciences For Up To $23B ↗
Under the deal, Exact Sciences shareholders will receive $105 per common share in cash. 
Via Stocktwits
News headline image
Why Exact Sciences Stock Blasted Nearly 24% Higher Today ↗
A strategic investor is reportedly in advanced talks to purchase the company. 
Via The Motley Fool
News headline image
2 Surging Stocks with Competitive Advantages and 1 We Question
The stocks in this article are all trading near their 52-week highs. This strength often reflects positive developments such as new product launches, favorable industry trends, or improved financial... 
Via StockStory
News headline image
The 5 Most Interesting Analyst Questions From Exact Sciences’s Q3 Earnings Call
Exact Sciences’ third quarter results received a positive response from the market, reflecting strong revenue growth and robust execution in its core screening business. Management attributed the... 
Via StockStory
Topics Earnings
News headline image
2 Brilliant Growth Stocks to Buy Now and Hold for the Long Term ↗
These companies are slowly coming into their own. 
Via The Motley Fool
News headline image
Why Exact Sciences Stock Blasted Higher on Tuesday ↗
An impressive beat-and-raise third quarter made the company a standout that day. 
Via The Motley Fool
News headline image
Palantir Weighs On Wall Street, Bitcoin Slumps 5%: What's Moving Markets Tuesday? ↗
Risk appetite cooled on Tuesday as investors interpreted the latest batch of corporate earnings as solid but not spectacular, offering a convenient excuse to take profits after strong year-to-date... 
Via Benzinga
News headline image
These Analysts Raise Their Forecasts On Exact Sciences Following Better-Than-Expected Q3 Results ↗
 
Via Benzinga
News headline image
Amazon To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Tuesday ↗
 
Via Benzinga
News headline image
EXAS Q3 Deep Dive: Cologuard Plus, Care Gap Programs, and New Test Launches Drive Growth
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year... 
Via StockStory
News headline image
Exact Sciences (EXAS) Q3 2025 Earnings Transcript ↗
Exact Sciences (EXAS) Q3 2025 Earnings Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Exact Sciences (NASDAQ:EXAS) Reports Upbeat Q3, Stock Soars
Diagnostic company Exact Sciences Corporation (NASDAQ:EXAS) reported revenue ahead of Wall Streets expectations in Q3 CY2025, with sales up 20% year on year to $850.7 million. The company’s full-year... 
Via StockStory
News headline image
Exact Sciences Flirts With A Breakout On Guidance Hike, Sales Beat ↗
Exact Sciences stock jumped late Monday on strong third-quarter sales, despite continued losses. The company raised its sales guide. 
Via Investor's Business Daily
Topics Earnings
News headline image
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
Nvidia, Amazon Extend Rally, Bitcoin Sinks To $107,000: What's Moving Markets Monday? ↗
Wall Street opened the week on a mixed note on Monday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
18 19 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.